Adhera Therapeutics Stock Total Debt
| ATRXDelisted Stock | USD 0.72 0.00 0.00% |
Adhera Therapeutics fundamentals help investors to digest information that contributes to Adhera Therapeutics' financial success or failures. It also enables traders to predict the movement of Adhera Pink Sheet. The fundamental analysis module provides a way to measure Adhera Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adhera Therapeutics pink sheet.
Adhera |
Adhera Therapeutics Company Total Debt Analysis
Adhera Therapeutics' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Adhera Therapeutics Total Debt | 7.35 M |
Most of Adhera Therapeutics' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adhera Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Adhera Therapeutics has a Total Debt of 7.35 M. This is 99.73% lower than that of the Biotechnology sector and 97.74% lower than that of the Health Care industry. The total debt for all United States stocks is 99.86% higher than that of the company.
Adhera Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adhera Therapeutics' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Adhera Therapeutics could also be used in its relative valuation, which is a method of valuing Adhera Therapeutics by comparing valuation metrics of similar companies.Adhera Therapeutics is currently under evaluation in total debt category among its peers.
Adhera Fundamentals
| Return On Asset | -4.48 | ||||
| Current Valuation | 10.55 M | ||||
| Shares Outstanding | 3.16 M | ||||
| Shares Owned By Insiders | 21.87 % | ||||
| Number Of Shares Shorted | 2.05 K | ||||
| Price To Earning | (125.83) X | ||||
| Price To Sales | 8.23 X | ||||
| Gross Profit | (157 K) | ||||
| EBITDA | (4.92 M) | ||||
| Net Income | (6.35 M) | ||||
| Cash And Equivalents | 849 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 7.35 M | ||||
| Debt To Equity | 56.30 % | ||||
| Current Ratio | 0.05 X | ||||
| Book Value Per Share | (6.90) X | ||||
| Cash Flow From Operations | (665 K) | ||||
| Short Ratio | 3.24 X | ||||
| Earnings Per Share | (0.52) X | ||||
| Number Of Employees | 12 | ||||
| Beta | -0.14 | ||||
| Market Capitalization | 2.18 M | ||||
| Total Asset | 196 K | ||||
| Retained Earnings | (42.43 M) | ||||
| Working Capital | 16.49 M | ||||
| Current Asset | 20.36 M | ||||
| Current Liabilities | 3.88 M | ||||
| Net Asset | 196 K |
About Adhera Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adhera Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adhera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adhera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Adhera Pink Sheet
If you are still planning to invest in Adhera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adhera Therapeutics' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |